TerminatedNot applicableNCT04178616

Assessment of the Prevalence of Olfactory Disorders in Systemic Scleroderma

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Lille
Principal Investigator
David Launay, MD,PhD
University Hospital, Lille
Intervention
olfactory testing with specific odorants (localisation and identification)(diagnostic_test)
Enrollment
59 enrolled
Eligibility
18 years · All sexes
Timeline
2019 – 2020

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04178616 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis →

← Back to all trials